Maria Guevara
About
In The Last Decade
Maria Guevara
11 papers receiving 241 citations
Peers
Comparison fields: 5 of 47
- Cellular and Molecular Neuroscience 140
- Pharmacology 139
- Psychiatry and Mental health 49
- Molecular Biology 41
- Cognitive Neuroscience 41
Countries citing papers authored by Maria Guevara
This map shows the geographic impact of Maria Guevara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Guevara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Guevara more than expected).
Fields of papers citing papers by Maria Guevara
This network shows the impact of papers produced by Maria Guevara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Guevara. The network helps show where Maria Guevara may publish in the future.
Co-authorship network of co-authors of Maria Guevara
This figure shows the co-authorship network connecting the top 25 collaborators of Maria Guevara. A scholar is included among the top collaborators of Maria Guevara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Guevara. Maria Guevara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | Pharmacogenetics and pain management: an opportunity to advance personalized patient care. | 4 |
| 3 | 19 | |
| 4 | 15 | |
| 5 | Evaluation of [18F]AZAN for quantification of nicotinic acetylcholine receptors in human brain | 1 |
| 6 | Evaluation of 11C-ABP688 and 18F-FPEB for imaging mGluR5 receptors in the human brain | 10 |
| 7 | 152 | |
| 8 | 1 | |
| 9 | Identification of region specific occupancy of mu-opioid receptors by fixed dose naltrexone in alcohol dependent subjects | 1 |
| 10 | Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR | 9 |
| 11 | PET experience with 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]FA) in the living human brain of smokers and nonsmokers | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.